baber/WOPTO huggingface dataset:
Patent AU-1223099-A (AU)
Title: Pharmaceutical formulation for stimulating the growth of gram-positive bacil li and increasing the acidity in vagina and the use thereof
Inventor: ZENG ZHONGMING
IPC: A61K9/00
Filed: 1998-11-24
Abstract: The present invention relates to a pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in the vagina which comprises sucrose and/or maltose, to the use of sucrose and/or maltose in preparing the pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in the vagina, in particular to a method for stimulating the growth of gram-positive bacilli and increasing the acidity in the vagina, treating the reduction of gram-positive bacilli and the lowness of acidity in vagina as well as the vaginitis and the disturbance of vaginal bacterioflora accompanying the reduction of gram-positive bacilli, especially bacterial vaginal disease, which applies sucrose and/or maltose.
Patent AU-1268801-A (AU)
Title: Fastening arrangement for fastening stays or shrouds to a boat mast
Inventor: LORENZEN JOHN
IPC: B63B15/02
Filed: 2000-11-06
Abstract: A fastening arrangement for fastening stays or shrouds (2) to a boat mast (4) comprises an elongated member (8) extending transversely to the mast (4) and being provided with a headed member (9, 11) in each end. Each headed member (9, 11) has a substantially spherical inner bearing surface (23) and a diametrically through-going slot extending axially from the bearing surface and to the outer end face of the headed member. A spherical body is arranged in each headed member (9, 11). The spherical body is arranged at the end of a stay and shroud (2) extending through the slot (21) and is adapted to abut the bearing surface (23). Each headed member (9, 11) is provided with an insertion opening (28) arranged opposite the bearing surface (23). The insertion opening allows for insertion of the spherical body (25) into the interior of the headed member (9, 11) to seat it on the bearing surface (23). A cap (32) is releasably arranged on an outer end portion (31) of each headed member (9, 11).
Patent AU-1446888-A (AU)
Title: Semi-synthetic rhodomycins, a process for their preparation and their use as cytostatics
Inventor: GERKEN MANFRED
IPC: C07H15/252
Filed: 1988-04-11
Abstract: Novel cytostatically active anthracyclines of the formula I, which are optionally present as a salt of an inorganic or organic acid <IMAGE> in which the radical R<1> is hydrogen or hydroxyl, R<2> is hydrogen, a structure of the formula II or IV or together with R<3> is a structure of the formula III, R<3> is hydrogen, a structure of the formula II or IV or together with R<2> is a structure of the formula III, R<4> is hydrogen, an acyl group, trimethylsilyl, a structure of the formula II or a structure of the formula IV <IMAGE> R<5> in this case is hydrogen, methyl, hydroxymethylene, acyloxymethylene or alkyloxymethylene, R<6> is hydrogen, hydroxyl, acyloxy, alkyloxy, allyloxy, benzyloxy or halogen, R<7> has the same meaning as R<6> and can additionally be NH2, NHacyl, N(alkyl)3, N(CH2CN)2, NH(CH2CN) or azido, and R<8> has the same meaning as R<6>, where the following compounds of the formula I are excepted:  1. R<1>=R<3>=R<4>=H, R<2>= alpha -L-daunosaminyl 2. R<1>=R<3>=R<4>=H, R<2>= alpha -L-rhodosaminyl or its 4'-acyl derivatives 3. R<1>=R<3>=H, R<2>=R<4>= alpha -L-rhodosaminyl or its 4'-acyl derivatives 4. R<1>=OH, R<3>=H, R<2>=R<4>= alpha -L-rhodosaminyl or its 4'-acyl derivatives 5. R<1>=R<2>=R<3>=H, R<4>= alpha -L-rhodosaminyl or its 4'-acyl derivatives.
Patent AU-1921097-A (AU)
Title: Continuous-casting mould
Inventor: PLESCHIUTSCHNIGG FRITZ-PETER
IPC: B22D11/04
Filed: 1996-12-03
Abstract: PCT No. PCT/DE96/02375 Sec. 371 Date Aug. 18, 1998 Sec. 102(e) Date Aug. 18, 1998 PCT Filed Dec. 3, 1996 PCT Pub. No. WO97/24196 PCT Pub. Date Jul. 10, 1997The invention relates to a process and a continuous-casting mold for casting thin slabs. The mold has an oblong inner cross-sectional area and cooled mold walls. The melt is poured in through at least one delivery nozzle which dips into the melt. To ensure that, during casting, markedly lower stresses and, as a consequence thereof, fewer cracks appear in the strand shell, at least at the casting level being established and at least over a part of the depth of immersion of the delivery nozzle, the ratio of the gap widths STI and SII/2 and the ratio of the cooling capacities LTI and LII of the mold wall are related by the equation: [STI/(SII/2)]/[LTI/LII]>1. STI is the width of the gap formed in the zone immediately surrounding the particular immersed delivery nozzle by the outer surface of the delivery nozzle and by the inner surface of the directly opposite mold wall, and SII/2 is half the width of the gap formed by the inner surfaces in the zones in which the inner surfaces of the mold walls are directly opposite each other. LTI and LII are the cooling capacities of the zones of the mold wall which form the respective gap or gap section.
Patent AU-1921492-A (AU)
Title: Chordal keyboard method and apparatus
IPC: G06F3/023
Filed: 1992-04-17
Abstract: A chordal keyboard method and apparatus for generating a key code using a plurality of keys coupled to a controller with a first set of registers and a second set of registers. A user depresses at least one of the plurality of keys. The controller detects, which of the plurality of keys are in a depressed position and which of the plurality of keys are released from the depressed position. The controller sets in the first set of registers and sets in the second set of registers, bit locations of respective depressed keys, and clears in the second set of registers bit locations of respective released keys. When the controller detects that all of the plurality of keys are in a released position, a key code is generated which corresponds to bit locations set in the first set of registers. After generating the key code, the controller clears the first set of registers.
Patent AU-1934392-A (AU)
Title: Ink jet recording apparatus
IPC: B41J2/17
Filed: 1992-06-30
Abstract: An ink jet recording apparatus which has at least one ink jet recording head (1) to perform recording on a recording medium (9) held on a rotary drum (8) by discharging liquid ink from discharging nozzles, comprises a receptor (11), arranged on the rotary drum (8) at a position which does not overlap with a position at which a recording medium (9) is placed, for receiving ink droplets discharged by the ink jet recording head (1) not for recording.
Patent AU-2010700-A (AU)
Title: Spring device, e.g. for the leg of a children's bed
Inventor: AGNAS KATARINA
IPC: A47B91/00
Filed: 1999-11-23
Abstract: The present invention relates to a spring device, preferably adapted to be used as an accessory to a child's bed, said device comprising a compression spring means (11) and a fastening means (12), by which the compression spring means (11) is adapted to be attached to an element, preferably a leg (13) of a child's bed, said fastening means (12) being provided in the area of one end of the compression spring means (11). Significant for the device according to the invention is that it comprises a casing (1; 1'; 1") of flexible material, said casing (1; 1'; 1") surrounding the compression spring means (11) in such a way that it extends in the axial direction of the compression spring means (11), from the end of the compression spring means (11) where the fastening means (12) is provided to the area of the opposite end of the spring compression means (11).
Patent AU-2055188-A (AU)
Title: Optical isomers
IPC: A61P25/28
Filed: 1988-08-08
Abstract: The (+)-cis-, (-)-cis-, (+)-trans- and (-)-trans- forms of 2-methylspiro(1,3-oxathiolan-5,3 min )quinuclidine <CHEM> are prepared by optical resolution of each of the (+/-)-cis- and (+/-)-trans-isomers. These compounds find application in treating diseases of the central nervous system in mammals, especially diseases due to a deficiency in the central cholinergic system. Biological tests indicate that the (-)-cis-form, as well as the (+/-)-cis-isomer, shows particular promise for treating senile dementia of Alzheimer's type.
Patent AU-2062797-A (AU)
Title: Apparatus and method of preparing electrochemical cells
Inventor: MITCHELL PORTER H
IPC: H01M50/426
Filed: 1997-03-04
Abstract: A method for removing plasticizers such dibutyl phthalate from the anode, cathode, and polymeric matrix components of electrochemical cell precursors using carbon dioxide in the supercritical state is provided. The method forms porous polymeric structures that enhances the mass transport of ions in the cell which results in improved electrochemical performance.
Patent AU-2099188-A (AU)
Title: Novel pyrrolidine-2,5-diones and 4,5,6,7-tetrahydroisoindole-1,3-diones
Inventor: MOSER HANS
IPC: C07D207/452
Filed: 1988-08-12
Abstract: The invention relates to novel, herbicidally active pyrrolidine- 2,5-diones and 4,5,6,7-tetrahydroisoindole-1,3-diones of the formula 
<IMAGE>
 in which
 R<1> represents hydrogen or (C1-C4)-alkyl;
 R<2> represents (C1-C4)-alkyl or
 R<1> and R<2> together represent a -(CH2)4- group which can be up to disubstituted by (C1-C4)-alkyl;
 X represents hydrogen or halogen;
 A represents 
<IMAGE>
 or O-R<4>
 R<3> represents hydroxyl; (C1-C8)-alkoxy; (C1-C4)-alkoxy-(C1-C4)-alkoxy; (C1-C4)-alkylthio-(C1-C4)-alkoxy; mono- or di-(C1-C4)- alkylamino-(C1-C4)-alkoxy; (C1-C8)-cyanoalkoxy; (C3-C8)-alkenyloxy; (C3-C8)-haloalkenyloxy; (C3-C8)-alkynyloxy; (C3-C7)-cycloalkyloxy; (C3-C7)-cycloalkyl-(C1-C4)-alkyloxy; halo-(C3-C7)-cycloalkoxy; optionally substituted benzyloxy, phenyloxy or phenylthio; the salt groups -O-Na, -O-K, -O-(Ca)0.5, -O-(Mg)0.5 or -O-NH4; amino; optionally substituted (C1-C4)-alkylamino or di-(C1-C4)-alkylamino; (C3-C4)-alkenylamino; diallylamino; N-pyrrolidino; -N-piperidino; -N-morpholino; N-thiomorpholino; -N-piperidazino; (C1-C8)-alkylthio; (C3-C8)-alkenylthio; benzylthio; optionally substituted (C1-C4)- alkylthio or (C1-C4)-alkoxy;
 R<4> represents (C1-C8)-alkyl, C3-C7-cycloalkyl, (C3-C7)-cycloalkyl-(C1-C4)-alkyl; (C3-C7)-halocycloalkyl; (C1-C8)-alkylcarbonyl; allylcarbonyl; optionally substituted benzylcarbonyl, benzoyl or dioxolanyl; furoyl; thienoyl; optionally substituted (C1-C4)-alkyl. 
<??>The preparation of the compounds of the formula I, herbicidal compositions containing compounds of the formula I, their use and processes for their preparation, and novel intermediates.
Patent AU-2368400-A (AU)
Title: Implantable ventricular assist device
Inventor: JASSAWALLA JAL S
IPC: A61M60/896
Filed: 1999-12-15
Abstract: An implantable ventricular assist device (VAD) has a small size to provide full-implantable capabilities. The VAD has two variable-volume chambers and an actuator for expelling blood from the chambers in sequence and to a common outlet, thus operating as a positive-displacement pump. The variable-volume chambers may be flexible sacs and the pump is operable at a substantially continuous flow, such as during the systolic phase of the assisted ventricle. A method of operation includes operating the pump at a first frequency during systole and a second lower frequency during diastole. The VAD pump includes a pair of coils housed within a frame and disposed in a spaced relationship to generate a coil flux through a pair of poles. A plate including an armature and a magnet is disposed within the frame such that the armature is between the poles and the magnet is between the coils. Gaps are defined between the armature and each of the poles and the coil flux displaces the armature across the gap. The coil flux follows a donut-shaped path including the frame, one of the poles, one of the gaps, the armature, the other the gap, and the other the pole, and no coil flux passes through the magnet. The magnet is not subject to depolarization and may be made substantially smaller than those of conventional devices. The magnet generates a bias flux that offsets a portion of the coil flux around the frame. A spring may be provided to counteract the unstable action of the bias magnet. The volume of the chambers is a fraction of the ventricular volume, and may be about 20 ml. To pump a typical 80-ml volume of a left ventricle, the controller may activate the coils four times during systole, or once every 40 msec.
Patent AU-2428795-A (AU)
Title: Composition and process for treating metal
Inventor: DOLLMAN DAVID Y DI
IPC: C23C22/57
Filed: 1995-05-08
Abstract: Heating an aqueous mixture of a fluoroacid such as H2TiF6 and an oxide, hydroxide, and/or carbonate such as silica produces a clear mixture with long term stability against settling of any solid phase, even when the oxide, hydroxide, or carbonate phase before heating was a dispersed solid with sufficiently large particles to scatter light and make the mixture before heating cloudy. The clear mixture produced by heating can either be mixed with water soluble and/or water dispersible polymers, for example with dispersed polymers of the diglycidyl ether of bisphenol-A or an acrylic acid polymer, or with soluble hexavalent and/or trivalent chromium, to produce a composition that improves the corrosion resistance of metals treated with the composition, especially after subsequent painting. Another composition that improves the corrosion resistance of metals after contact with them is an aqueous solution of a mixture of: (A') a water soluble or dispersible polymer having at least one -OH group per polymer molecule selected from the group consisting of polyvinyl alcohol, polyethylene glycol, modified starch, and mixtures thereof, and (B') polymers and copolymers of acrylic and methacrylic acid and their salts.
Patent AU-2433000-A (AU)
Title: Starch phosphates, method for the production thereof and their use
Inventor: PIESCHEL FRIEDEMANN
IPC: C08B31/06
Filed: 1999-12-20
Abstract: The invention relates to starch phosphates exhibiting improved properties with regard to application techniques, to a method for the production thereof, and to their use. Based on the disadvantages of the known prior art, the aim of the invention is to produce starch phosphates which have a high degree of substitution, which are resistant to hydrolysis, and which can be produced using phosphorylating agents comprising only a low level of toxicity. To this end, starch phosphates are provided in which the anhydroglucose units are substituted by phosphate ester groups and carbamide groups, and the average degree of substitution DS of the carbamide groups and of the phosphate ester groups is in a range, each time, that is greater than 0.01. The starting materials are used in a mol ratio of anhydroglucose units of the starch:phosphorus of the phosphorylating agent:urea of 1:0.1 to 1.5:0.3 to 4, and the reaction is carried out in a vacuum under a pressure of<=100 torr and at reaction temperatures ranging from 90° C. to 140° C. Starch phosphates exhibiting different properties are obtained by reacting at different reaction temperatures, are distinguished by a good biodegradability, and are resistant to hydrolysis under normal conditions.
Patent AU-2640397-A (AU)
Title: Disposable, foldable, unitary, compact animal excrement collecting device
Inventor: DUVILLE ANAIS
IPC: E01H1/12
Filed: 1997-04-03
Abstract: A device for collecting animal excrement (D) is disclosed, characterised in that it includes a box (50) with a base (7), two substantially triangular side walls (10, 11) and a lower wall (13), and a substantially flat lid (60) with a handle (21) and hinged at least about an axis (2, 3) substantially parallel to said lower wall adjacent the ends (10a, 11a) of said side walls facing the lower wall. The device is completely unitary and is formed by folding and gluing a cardboard sheet with an integral handle formed by cutting out the central area of the lid, which is twice as thick beneath the handle. This device has a compact position in which it is glued into a closed state and can be stored without being deformed, an expanded position in which it is locked into a rigid state and a position in which it is locked into a sealed state after use.
Patent AU-2645597-A (AU)
Title: Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
Inventor: COPLEY CLIVE GRAHAM
IPC: A61K47/48
Filed: 1997-04-29
Abstract: An anti-CEA monoclonal antibody, designated 806.077, of murine origin is useful for the diagnosis and therapy of cancer. The antibody complementarity determining regions have the following sequences: heavy chain CDR1 DBYMH CDR2 WIDPENGDTE YAPKFRG, CDR3 LIYAGYLAMD Y; and light chain CDR1 SASSSVTYMH, CDR2 STSNLAS, CDR3 QQRSTYPLT. The antibody optionally is humanized and can be in the form of a conjugate with either an enzyme, such as carboxypeptidase, or a co-stimulatory molecule such as the extracellular domain of human B7.1.
Patent AU-2661295-A (AU)
Title: Personal care compositions containing thermoplastic elastomeric graft copolymers
Inventor: TORGERSON PETER MARTE
IPC: A61Q5/06
Filed: 1995-05-31
Abstract: The present invention relates to hair care compositions containing nonpolar graft thermoplastic elastomeric copolymers and a water insoluble volatile solvent for the copolymer. This invention relates to styling products such as sprays and mousses, to hair conditioning products such as rinses and leave on conditioners, and to shampoo products useful for both cleansing and conditioning the hair.
Patent AU-3000601-A (AU)
Title: Method for production of a skin graft and the graft produced thereby
Inventor: THIERAUF AXEL
IPC: A61K35/12
Filed: 2000-12-08
Abstract: The invention relates to a method for the production of a skin graft, in particular a skin autograft, whereby skin cells are placed on the surface of a culture medium and allowed to grow. A surface element, in particular a webbing or fabric, made from a biocompatible, biologically degradable and/or absorbable material is placed on the culture medium, along which the skin cells, placed on the culture medium, grow and multiply, whereby the fibres of the surface element have a diameter of 5 to 20  mu m.
Patent AU-3017189-A (AU)
Title: Bone cement
Inventor: ARROYO NESTOR A
IPC: A61L24/04
Filed: 1989-02-21
Abstract: There is disclosed a bone cement composition comprising (a) a liquid component comprising a monomer of an acrylic ester and (b) a powdered component comprising, based on the weight of the powdered component,   (i) from 0 to about 20 percent of a methyl methacrylate homopolymer,   (ii) from about 30 to about 60 percent of a methyl methacrylate-styrene copolymer, and (iii) from about 30 to about 60 percent of a methyl methacrylate-butyl methacrylate copolymer. i
Patent AU-3240700-A (AU)
Title: Method and apparatus for continuously calcining gypsum
Inventor: PIASECKI ROBERT J
IPC: B01D11/02
Filed: 2000-02-23
Abstract: An apparatus for continuously calcining gypsum includes a flash calcining impact mill, a feed bin adjacent the impact mill for holding gypsum, and a gypsum feed control mechanism for supplying gypsum from the feed bin to the impact mill at a substantially constant rate. A method for continuously producing calcined gypsum includes the steps of providing a flash calcining impact mill and providing a feed bin adjacent the impact mill, the feed bin containing gypsum to be calcined. A gypsum feed control mechanism is provided for supplying gypsum from the feed bin to the impact mill. Gypsum is supplied from the feed bin to the impact mill at a substantially constant rate, and the impact mill is operated to dry, grind, and calcine the gypsum.
Patent AU-3255200-A (AU)
Title: New substituted pyridine or piperidine compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: YU CHU-YI
IPC: C07D211/22
Filed: 2000-05-05
Abstract: Pyridine and piperidine derivatives (I) are new. Pyridine and piperidine derivatives of formula (I), their enantiomers and diastereoisomers, acid and base salts, are new. A = pyridine, pyridinium, or piperidine; R2 = H; R3 = OH, or together with R2 forms oxo; R4 = phenyl, naphthyl or heteroaryl (all optionally substituted); R1 = H or R1 - R4, together with the two C atoms to which they are attached, form a 6C ring, or R1 and R2 form a bond, in which case R3 is a 5- or 6-membered heterocycle linked through N and which may contain a further hetero atom (O, N, S); R5 = a 5-6 membered heterocycle linked through N optionally containing a hetero atom (O, N, S), or a group of formula (II); R'1-R'4 = have the same meanings as R1-R4, or they may be H, in which case R4 is not unsubstituted phenyl, naphthyl, or heteroaryl; R6 = H, 1-6C alkyl or absent; with the provisos that (a) when A = piperidine, R2-R3 form oxo, R5 = H, and R6 =H or is absent, then R4 is other than phenyl substituted by one group OH, alkoxy, CF3, or halogen other than Br, or by more than one group OH and alkoxy, (b) when R2 = H, R3 = OH, R5 = H, R6 = H or is not there, then R4 is not phenyl substituted by one Cl, OH, alkoxy or alkyl group, or by more than one OH or alkoxy group and (c) (I) is not 1-(1,3-benzodioxol-5-yl)-2-(2-pyridinyl) ethanol or 2-(2-pyridinyl) cyclohexanone.
Patent AU-3515499-A (AU)
Title: Tear band for packages
Inventor: PUTTKAMMER FRANK
IPC: B65D65/34
Filed: 1999-02-26
Abstract: Before the tear-off strip (1) is connected to the packaging film, it is stretched in sections on the left and/or right, on the upper (7) and/or lower side (6). This stretching serves as coding. Number and/or radii and/or height of the waves created before connection and after tearing-open, show coding of information. The tear-off strip may also have a number of punched perforations (5), which may represent company logos or trademarks. The strip may also have metallised sections, and within these sections, numbers or letters are non-metallised. -
Patent AU-3610593-A (AU)
Title: Ligands for improving metal chelate formation kinetics
Inventor: SRINIVASAN ANANTHACHARI
IPC: A61K51/00
Filed: 1993-02-05
Abstract: Amide-thiolate ligands having improved metal chelate formation kinetics are disclosed. The ligands include an amine to facilitate rapid formation of an amine-amide-thiolate intermediate complex, followed by transfer of the metal to or conversion of the ligand to a thermodynamically stable amide-thiolate complex. In one embodiment of the invention, the amine is a tertiary amine, or its equivalent, strategically located to facilitate complex formation. In another embodiment of the invention, the amine is part of pyridine containing a lower alkoxy substituent in the 2 or 4 ring position. O-dealkylation occurs upon complexation causing the amine to become a vinylogous amide as part of a thermodynamically stable amide-thiolate complex. The amide-thiolate ligands of the present invention may be used for post formed labeling of biological substances for use in the fields of diagnosis and therapy.
Patent AU-3613000-A (AU)
Title: C16 unsaturated fp-selective prostaglandins analogs
Inventor: DELONG MITCHELL ANTHONY
IPC: C07C405/00
Filed: 2000-02-29
Abstract: Compounds having a structure according to the following formula:are effective in treating disorders such as bone disorders and glaucoma in a subject in need thereof.
Patent AU-3664895-A (AU)
Title: Device for storing picture or code information displayed on a screen, carrier cards for such devices and method for the transmission of a code
Inventor: HOHENACKER THOMAS
IPC: H04H60/31
Filed: 1995-11-03
Abstract: The storage device is used to store image information, e.g. a code, displayed in a given area of the monitor screen using a photosensitive storage medium (2) attached to the surface of the screen via an adhesive layer. Pref. the photosensitive material is applied to a flat carrier which has a screening layer overlying the photosensitive material on the screen side, so that the photosensitive material only cooperates with the screen in defined relatively spaced regions, corresponding to transparent areas of the screening layer.